TuHURA Biosciences, Inc. HURA
1.36 USD -0.01 (-0.73%)
Regular-session close
1.31 -0.05 -3.38%
After hours · Nov 19, 5:17 PM ET
1.36 Day range 1.46
0.41 52-week range 3.43
- YTD
- +79.66%
- 1 year
- -22.29%
News
benzinga.com HC Wainwright & Co. Reiterates Buy on TuHURA Biosciences, Maintains $10 Price Target HC Wainwright & Co. analyst Robert Burns reiterates TuHURA Biosciences (NASDAQ:HURA) with a Buy and maintains $10 price target.
benzinga.com TuHURA Biosciences Q3 EPS $(0.10) Beats $(0.14) Estimate TuHURA Biosciences (NASDAQ:HURA) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.14) by 23.08 percent. This is a 28.57 percent increase over losses of…
prnewswire.com TuHURA Biosciences Reports Third Quarter 2026 Financial Results and Provides a Corporate Update TAMPA, Fla., Nov. 13, 2026 /PRNewswire/ -- TuHURA Biosciences, Inc. (NASDAQ:HURA) ("TuHURA" or the "Company"), a Phase 3 immuno-oncology company developing novel therapeutics to overcome resistance…benzinga.com HC Wainwright & Co. Reiterates Buy on TuHURA Biosciences, Maintains $10 Price Target HC Wainwright & Co. analyst Robert Burns reiterates TuHURA Biosciences (NASDAQ:HURA) with a Buy and maintains $10 price target.
benzinga.com TuHURA Reports Initial Data Showing Partial Responses In First Three Metastatic Merkel Cell Carcinoma Patients Treated With Ifx-2.0 Plus Keytruda Preliminary results demonstrate major objective tumor responses in first 3 patients at 6 months Company to host a webcast today, October 26, 2026, at 8:30 am ETTAMPA, Fla., Oct. 26, 2026 /PRNewswire/…
